[Asia Economy Reporter Minji Lee] Shares of the three companies under Celltrion (Celltrion, Celltrion Healthcare, Celltrion Pharm) have been rising following news of their planned merger.


On the 28th at 9:09 AM in the KOSPI market, Celltrion was trading at 263,000 KRW, up 1.74% from the previous session. In the KOSDAQ market, Celltrion Healthcare was trading at 91,100 KRW, up 3.88%, and Celltrion Pharm was up 13.07% at 116,800 KRW.



Myungseon Lee, a researcher at Shin Young Securities, stated, “Through the merger, the company will become a global-level comprehensive healthcare firm covering everything from synthetic drugs to biopharmaceuticals.” He added, “With a massive 52 trillion KRW healthcare company listed on the KOSPI, passive funds from both domestic and international investors are expected to flow in, potentially making it the third largest company by market capitalization after SK Hynix.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing